Home › Funds › Patient Square Capital LP › ONC
Patient Square Capital LP position in ONC
BEONE MEDICINES LTD · Health Care
Patient Square Capital LP reported holding 33,500 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 1.96% of its reported portfolio and ranking #13 among its reported holdings. Patient Square Capital LP has disclosed ONC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Square Capital LP's ONC position evolved
Patient Square Capital LP first disclosed a stake in ONC in Q4 2025 at 69,312 shares (US$21.1M). The position peaked in Q2 2026 at 90,020 shares, worth US$25.7M. Across 4 filings, Patient Square Capital LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 33,500 shares valued at US$12.3M — a reduction of -56,520 shares quarter over quarter.. Notable position changes include a 63% trim in Q3 2026 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 69.31K | $21.06M | New |
| Q1 2026 | 80.54K | $23.92M | Add |
| Q2 2026 | 90.02K | $25.65M | Add |
| Q3 2026 | 33.50K | $12.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONC and 13F data
ONC (BEONE MEDICINES LTD) is a Health Care company. 30 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.80B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ONC
- BAKER BROS. ADVISORS LP 8.80M sh · $2.51B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 4.91M sh · $1.80B · Q3 2026
- Temasek Holdings 845.73K sh · $241.01M · Q2 2026
- Siren, L.L.C. 465.00K sh · $170.16M · Q3 2026
- Candriam S.C.A. 289.24K sh · $106.23M · Q3 2026
- Capital International, Inc./CA/ 290.16K sh · $106.18M · Q3 2026
- Capital International Sarl 206.19K sh · $75.45M · Q3 2026
More on Patient Square Capital LP
FAQ
How long has Patient Square Capital LP held ONC?
Patient Square Capital LP has disclosed ONC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Patient Square Capital LP's current position in ONC?
As of Q3 2026, Patient Square Capital LP holds 33.50K shares of ONC (BEONE MEDICINES LTD), valued at $12.26M, representing 1.96% of its reported portfolio and ranking #13.
Has Patient Square Capital LP been buying or selling ONC?
In the latest 13F filing (Q3 2026), Patient Square Capital LP reduced its position in ONC. The position peaked in Q2 2026 at 90.02K shares.
Which other funds hold ONC?
Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.